	MicroRNA-mediated modulation of cancer-associated fibroblasts in HER2-positive breast tumor microenvironment: a comprehensive review. Discov Oncol Ardah MT, Abdulsahib WK, Naji HA, Jyothi SR, Sahoo S, Janney JB, Sharma V, Sinha A, Kholiyeva M. PMID: 41604098 [PubMed - as supplied by publisher]
	Circulating sPD-L1 as a tumor microenvironment-derived biomarker: enhancing diagnostic discrimination accuracy in breast cancer. Cancer Immunol Immunother Zhang Y, Chen S, Ma J, Sun X, Zhou X. PMID: 41603965 [PubMed - indexed for MEDLINE]
	Anticancer Activity of Picolinamide and Sulfur Chelated Pt(II) Complexes Against Breast Cancer: In Vitro Interaction Studies Through Molecular Docking With Bio-Receptors. Chem Asian J Chatterjee S, Mandal S, Das C, Bhaduri R, Arka Bagchi, Biswas A, Moi SC. PMID: 41603502 [PubMed - indexed for MEDLINE]
	Metformin-Mediated Glycaemic Regulation as a Potential Strategy for Breast Cancer Prevention. Cancer Med Jinadasa AGRG, Wageesha NDA, Samarakoon SR, Ekanayake S, Akalanka HMK. PMID: 41603225 [PubMed - indexed for MEDLINE]
	Prognosis of Metaplastic Breast Cancer: A Population-Based Matched Cohort Study. Cancer Med Bergman M, Schiza A, Boyaci C, Acs B, Matikas A, Hartman J, Valachis A. PMID: 41603205 [PubMed - indexed for MEDLINE]
	Integration of ultrasonography and circulating tumor DNA analysis enhances early detection of asymptomatic ovarian cancer. Ginekol Pol Jiapaer R, Ma Y. PMID: 41603161 [PubMed - as supplied by publisher]
	Lymphovenous anastomosis: microsurgical innovation and clinical outcomes in breast cancer-related lymphedema care. Front Surg Lee CJ, Hong ES, Rhee DJ, Choi D. PMID: 41602929 [PubMed]
	Feasibility of an ACT-based group intervention for Malaysian breast cancer survivors with chronic pain. Front Psychol Lim JH, Ahmad M. PMID: 41602726 [PubMed]
	Postoperative exercise rehabilitation and patient experience among breast cancer survivors under the "Healthy China" initiative: an integrative review. Front Psychol Zhao B, Li X, Fu C, Bian Y, Gong Y, Zhu L, Wang X. PMID: 41602721 [PubMed]
	HPV, APOBEC3B, and the origins of breast cancer: a narrative review and perspectives on novel mechanisms. Front Oncol Liu ZY, Chen R. PMID: 41602431 [PubMed]
	Ultrasound-based radiomics for the evaluation of breast cancer. Front Oncol Sun FY, Meng DL, Liu L, Cao XQ, Fu L, Meng L, Cui XW, Pan XF. PMID: 41602430 [PubMed]
	Liquid biopsy in triple-negative breast cancer: a promising tool for diagnosis, prognosis, and treatment monitoring. Front Oncol Brogna MR, Ferrara G, Varone V, Montone A, Fava A, Schiano MR, Del Sesto M, Pizza N, Prota A, Barra C, Collina F. PMID: 41602389 [PubMed]
	Prognostic value of micro-RNA in ovarian cancer: a systematic review and meta-analysis. Front Oncol He Z, Deng L, Wang Z. PMID: 41602377 [PubMed]
	Predictive value of the KELIM in neoadjuvant treatment for patients with advanced ovarian cancer. Front Oncol Wang Y, Yu Y, Yuan H, Wang L, Bian P, Yang Y, Wang J. PMID: 41602373 [PubMed]
	Hyperthermic intraperitoneal chemotherapy in ovarian cancer: a comprehensive review. Front Oncol Li Y, Xu X. PMID: 41602365 [PubMed]
	Global consensus for the screening, diagnosis, staging, treatment, and surveillance of ovarian cancer in areas of significant resource limitations: report from the International Gynecological Cancer Society consensus meeting. Front Oncol Maluf F, Helber HA, Tostes F, Maluf LA, Helito JK, Moretti-Marques R, Dal Molin GZ, Azevedo BRB, Ortiz DI, Cantu D, Silva Filho AL, Nogueira-Rodrigues A, Ribeiro R, Cintra GF, Guitmann G, de Melo AC, Paulino E, Baiocchi G, Resende L, de Almeida MS, de Andrade DA, de la Vega JL, Noll F, Fin F, Lopes A, Correa ME, Ng JS, Sanabria D, Rendon G, Heredia F, Lopes APE, Mussi MB, Bobinski M, Quintanilla MP, Meymar J, Atallah D, Tsunoda A. PMID: 41602363 [PubMed]
	The diagnostic value of serum inflammation, coagulation and tumor indexes in differentiating stage III and IV ovarian endometriotic cysts. Front Med (Lausanne) Lu LJ, Liu XF, Xing YY. PMID: 41601772 [PubMed]
	Decoding inflammatory regulation in ovarian cancer at single-cell resolution. Front Immunol Yu J, Zhou T, Chen S, Zhu J, Xu L, He Y, Chen W. PMID: 41601649 [PubMed - indexed for MEDLINE]
	Sacituzumab govitecan as a therapeutic breakthrough in the treatment of triple-negative breast cancer: a systematic review of clinical trials. Front Immunol Piekarz J, Picheta N, Pobide, Szklener K, Skórzewska M. PMID: 41601628 [PubMed - indexed for MEDLINE]
	Current status and associated factors of social avoidance in postoperative breast cancer patients: a cross-sectional study. Front Psychiatry Chen X, Yang X, Zhang Q, Chu T, Zhang J, Ma L, Chen L, Zhao J. PMID: 41601494 [PubMed]

Articles 1 - 20 / 323497

Page 1 of 16175



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy